½ÉÀå ¹Úµ¿ °ü¸® ÀåÄ¡ ½ÃÀå : Á¦Ç°º°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°
Cardiac Rhythm Management Devices Market, By Product, By Application, By End users, By Geography
»óǰÄÚµå : 1672907
¸®¼­Ä¡»ç : Coherent Market Insights
¹ßÇàÀÏ : 2025³â 02¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹®
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,500 £Ü 6,385,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 7,000 £Ü 9,933,000
PDF (Multi User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 7¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 10,000 £Ü 14,191,000
PDF (Enterprise User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

½ÉÀå ¹Úµ¿ °ü¸® ÀåÄ¡ ¼¼°è ½ÃÀåÀº 2025³â¿¡ 182¾ï 5,000¸¸ ´Þ·¯, 2032³â¿¡´Â 243¾ï 5,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 2025-2032³â°£ ¿¬Æò±Õ 4.2% ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

º¸°í ¹üÀ§ º¸°í¼­ »ó¼¼ ³»¿ë
±âÁØ ¿¬µµ 2024³â 2025³â ½ÃÀå ±Ô¸ð 182¾ï 5,000¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2020-2024³â ¿¹Ãø ±â°£ 2025-2032³â
¿¹Ãø ±â°£(2025-2032³â) CAGR 4.20% 2032³â ±Ý¾× ¿¹Ãø 243¾ï 5,000¸¸ ´Þ·¯
±×¸². 2025³â Áö¿ªº° ½ÉÀå ¹Úµ¿ °ü¸® ÀåÄ¡ ½ÃÀå Á¡À¯À²(%)
Cardiac Rhythm Management Devices Market-IMG1

½ÉÀå ¹Úµ¿ °ü¸®¿¡´Â ºü¸¥ ½ÉÀå ¹Úµ¿, ´À¸° ½ÉÀå ¹Úµ¿, ºÒ±ÔÄ¢ÇÑ ½ÉÀå ¹Úµ¿ÀÇ Áø´Ü, Ä¡·á ¹× ¿¹¹æÀÌ Æ÷ÇԵ˴ϴÙ. ½ÉÇ÷°ü ÁúȯÀÇ À¯º´·ü Áõ°¡¿Í Àü ¼¼°è ³ëÀÎ Àα¸ Áõ°¡´Â ½ÉÀå ¹Úµ¿ °ü¸® ÀåÄ¡¿¡ ´ëÇÑ ¼ö¿ä¸¦ Áõ°¡½Ãų ¼ö ÀÖ½À´Ï´Ù. ±â¼úÀÇ ¹ßÀüÀ¸·Î ¼ÒÇüÈ­µÈ À̽ÄÇü ±â±âÀÇ °³¹ßÀÌ °¡´ÉÇØÁ® ȯÀÚµéÀÇ »îÀÇ ÁúÀ» Çâ»ó½Ãų ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ±×·¯³ª ¼ö¼ú ¹× ÀåºñÀÇ ³ôÀº ºñ¿ëÀº ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ½ÉÀå ¹Úµ¿ °ü¸® ÀåÄ¡ ½ÃÀåÀÇ ¼ºÀåÀº ½ÅÈï±¹¿¡¼­ÀÇ Á¦Ç° ½ÂÀÎ Áõ°¡¿Í È®´ë°¡ ÁÖµµÇϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ

½ÉÀå ¹Úµ¿ °ü¸® ÀåÄ¡ ¼¼°è ½ÃÀå °³Ã´Àº ½ÉÀå ¸®µë ÀÌ»ó°ú °ü·ÃµÈ ½ÉÇ÷°ü ÁúȯÀÇ À¯º´·ü Áõ°¡¿Í ÷´Ü À̽ÄÇü ±â±â °³¹ß·Î À̾îÁö´Â ±â¼ú ¹ßÀüÀÌ ¿øµ¿·ÂÀÌ µÇ°í ÀÖÀ¸¸ç, ¼¼°èº¸°Ç±â±¸(WHO)¿¡ µû¸£¸é ½ÉÇ÷°ü ÁúȯÀ¸·Î ÀÎÇÑ ¿¬°£ »ç¸ÁÀÚ ¼ö´Â 1,700¸¸ ¸íÀ» ³Ñ¾î¼¹À¸¸ç, ±× Áß ´ëºÎºÐÀÌ ºÎÁ¤¸ÆÀ¸·Î ÀÎÇÑ »ç¸ÁÀÚÀÔ´Ï´Ù. ºÎÁ¤¸ÆÀÌ ¿øÀÎÀÔ´Ï´Ù. °í·ÉÈ­·Î ÀÎÇØ ºÎÁ¤¸ÆÀÇ ¹ßº´ À§ÇèÀÌ ³ô¾ÆÁü¿¡ µû¶ó °í·ÉÀÚ °³¹ßµµ ½ÃÀå °³Ã´ÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. ±×·¯³ª ÷´Ü À̽ÄÇü ÀåÄ¡ÀÇ ³ôÀº °¡°Ý°ú ÀÌ½Ä ¼ö¼úÀÌ ½ÃÀå ¼ºÀå¿¡ °É¸²µ¹ÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ½ÃÀå ÁøÃâ±â¾÷µéÀº º¸´Ù »õ·Î¿î ¿ëµµÀÇ Çõ½ÅÀûÀÎ µð¹ÙÀ̽ºÀÇ ½ÂÀÎÀ» ȹµæÇϰí, ´ë¸®Á¡°úÀÇ Á¦ÈÞ ¹× JV¸¦ ÅëÇØ ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ½ÅÈï ±¹°¡·Î ÁøÃâÇÔÀ¸·Î½á »õ·Î¿î ±âȸ¸¦ È®ÀÎÇÒ ¼ö ÀÖ½À´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

¼¼°èÀÇ ½ÉÀå ¹Úµ¿ °ü¸® ÀåÄ¡(Heart Rhythm Management Device) ½ÃÀå¿¡ ´ëÇØ Á¶»ç ºÐ¼®ÇßÀ¸¸ç, 2024³âÀ» ±âÁØ ¿¬µµ·Î ÇÏ¿© ¿¹Ãø ±â°£(2025-2032³â) ½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯)¿Í ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» Á¶»çÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

¶ÇÇÑ, ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀû ¼öÀÍ ±âȸ¸¦ ¹àÈ÷°í, ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.

¶ÇÇÑ ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÇ °æÀï Àü·« µî¿¡ ´ëÇÑ Áß¿äÇÑ °íÂûÀ» Á¦°øÇÕ´Ï´Ù.

ÀÌ º¸°í¼­´Â ±â¾÷ ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, À繫 ¼º°ú, Àü·« µîÀÇ ¸Å°³ º¯¼ö¸¦ ±â¹ÝÀ¸·Î ¼¼°è ½ÉÀå ¹Úµ¿ °ü¸® ÀåÄ¡ ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏÀ» Á¦°øÇÕ´Ï´Ù.

ÁÖ¿ä ±â¾÷À¸·Î´Â Medtronic, Abbott, Boston Scientific, BIoTronik, LivaNova µîÀÌ ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­ÀÇ ÀλçÀÌÆ®¸¦ ÅëÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀº ÇâÈÄ Á¦Ç° Ãâ½Ã, À¯ÇüÈ­, ½ÃÀå È®´ë, ¸¶ÄÉÆÃ Àü·«¿¡ ´ëÇÑ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.

½ÉÀå ¹Úµ¿ °ü¸® ÀåÄ¡ ¼¼°è ½ÃÀå º¸°í¼­´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô ½ÃÀå ÁøÃâ±â¾÷, À繫 ºÐ¼®°¡ µî ÀÌ »ê¾÷ÀÇ ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀº ¼¼°è ½ÉÀå ¹Úµ¿ °ü¸® ÀåÄ¡ ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤À» ½±°Ô ³»¸± ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¸ñÀû°ú ÀüÁ¦Á¶°Ç

Á¦2Àå ½ÃÀå Àü¸Á

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

Á¦4Àå ¼¼°èÀÇ ½ÉÀå ¹Úµ¿ °ü¸® ÀåÄ¡ ½ÃÀå - Äڷγª¹ÙÀÌ·¯½º(COVID-19) ÆÒµ¥¹ÍÀÇ ¿µÇâ

Á¦5Àå ¼¼°èÀÇ ½ÉÀå ¹Úµ¿ °ü¸® ÀåÄ¡ ½ÃÀå, Á¦Ç°º°, 2020-2032³â(10¾ï ´Þ·¯)

Á¦6Àå ¼¼°èÀÇ ½ÉÀå ¹Úµ¿ °ü¸® ÀåÄ¡ ½ÃÀå, ¿ëµµº°, 2020-2032³â(10¾ï ´Þ·¯)

Á¦7Àå ¼¼°èÀÇ ½ÉÀå ¹Úµ¿ °ü¸® ÀåÄ¡ ½ÃÀå, ÃÖÁ¾»ç¿ëÀÚº°, 2020-2032³â(10¾ï ´Þ·¯)

Á¦8Àå ¼¼°èÀÇ ½ÉÀå ¹Úµ¿ °ü¸® ÀåÄ¡ ½ÃÀå, Áö¿ªº°, 2020-2032³â(10¾ï ´Þ·¯)

Á¦9Àå °æÀï ±¸µµ

Á¦10Àå ¾Ö³Î¸®½ºÆ® Ãßõ »çÇ×

Á¦11Àå Á¶»ç ¹æ¹ý

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Cardiac Rhythm Management Devices Market is estimated to be valued at USD 18.25 Bn in 2025 and is expected to reach USD 24.35 Bn by 2032, growing at a compound annual growth rate (CAGR) of 4.2% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 18.25 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 4.20% 2032 Value Projection: USD 24.35 Bn
Figure. Cardiac Rhythm Management Devices Market Share (%), By Region 2025
Cardiac Rhythm Management Devices Market - IMG1

Cardiac rhythm management includes diagnosis, treatment, and prevention of fast, slow, or irregular heartbeats. Rising prevalence of cardiovascular diseases and growing geriatric population worldwide can boost demand for cardiac rhythm management devices. Technological advancements have enabled development of miniaturized implantable devices, offering improved quality of life to patients. However, high costs of surgical procedures and devices can hamper the market growth. Cardiac rhythm management devices market growth is driven by rising product approvals and expansions in emerging nations.

Market Dynamics:

Global cardiac rhythm management devices market growth is driven by rising prevalence of cardiovascular disorders associated with heart rhythm abnormalities and technological advancements leading to development of sophisticated implantable devices. According to WHO, cardiovascular diseases account for over 17 million deaths annually, a majority of which are caused due to irregular heartbeats. Growing geriatric population also drives the market growth, as aging increases risk of developing arrhythmias. However, high costs of sophisticated implantable devices and surgical procedures to implant them can hamper the market growth. Market players can witness new opportunities by gaining approvals for innovative devices in newer applications and expanding to emerging countries in Asia Pacific, Latin America, and Middle East & Africa through distributor partnerships and JVs.

Key Features of the Study:

This report provides in-depth analysis of the global cardiac rhythm management devices market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global cardiac rhythm management devices market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Medtronic, Abbott, Boston Scientific, Biotronik, and LivaNova

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global cardiac rhythm management devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cardiac rhythm management devices market

Detailed Segmentation-

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Cardiac Rhythm Management Devices Market- Impact of Coronavirus (COVID-19) Pandemic

5. Global Cardiac Rhythm Management Devices Market, By Product, 2020 - 2032, (USD Bn)

6. Global Cardiac Rhythm Management Devices Market, By Application, 2020 - 2032, (USD Bn)

7. Global Cardiac Rhythm Management Devices Market, By End User, 2020 - 2032, (USD Bn)

8. Global Cardiac Rhythm Management Devices Market, By Region, 2020 - 2032, (USD Bn)

9. Competitive Landscape

10. Analyst Recommendations

11. Research Methodology

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â